Literature DB >> 10362637

Activation of VEGF and Ras genes in gastric mucosa during angiogenic response to ethanol injury.

M K Jones1, R M Itani, H Wang, M Tomikawa, I J Sarfeh, S Szabo, A S Tarnawski.   

Abstract

Our previous studies demonstrated that ethanol injury triggers the angiogenic response in gastric mucosa bordering necrosis. The present study was aimed to determine whether vascular endothelial growth factor (VEGF) (a potent angiogenic peptide selectively acting on endothelial cells) and Ras (a mediator of cell proliferation and a putative regulator of VEGF expression) are involved in gastric angiogenesis after ethanol injury. We studied the angiogenic response and expression of VEGF and Ras in gastric mucosa after ethanol injury. Ethanol damage triggered 1) angiogenesis in the gastric mucosa bordering necrosis, 2) significant increases in VEGF mRNA and protein expression, and 3) significant increases in the expression of Ki-ras mRNA and Ras proteins. Neutralizing anti-VEGF antibody significantly reduced (by greater than threefold) the angiogenic response to ethanol-induced injury. Moreover, mevastatin, an inhibitor of Ras activation, completely blocked the induction of VEGF expression in cultured primary endothelial cells. Because, in other tissues, VEGF is one of the most potent angiogenic factors and VEGF expression is dependent on Ras, our data indicate that Ras and VEGF are involved in gastric mucosal angiogenesis after ethanol injury.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10362637     DOI: 10.1152/ajpgi.1999.276.6.G1345

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  25 in total

Review 1.  Gut mucosal healing: is the science relevant?

Authors:  Marc D Basson
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

2.  Activation of c-Jun N-terminal kinase (JNK) signalling in experimentally induced gastric lesions in rats.

Authors:  K Mitsuyama; O Tsuruta; Y Matsui; K Harada; N Tomiyasu; A Suzuki; K Takaki; J Masuda; K Handa; Y Satoh; B L Bennett; A Toyonaga; M Sata
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

Review 3.  Cellular and molecular mechanisms of gastrointestinal ulcer healing.

Authors:  Andrzej S Tarnawski
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.199

Review 4.  Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer.

Authors:  José B Sáenz; Jason C Mills
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-02-21       Impact factor: 46.802

5.  Survivin is a key factor in the differential susceptibility of gastric endothelial and epithelial cells to alcohol-induced injury.

Authors:  M K Jones; O R Padilla; E Zhu
Journal:  J Physiol Pharmacol       Date:  2010-06       Impact factor: 3.011

Review 6.  Brain angiogenesis in developmental and pathological processes: mechanism and therapeutic intervention in brain tumors.

Authors:  Woo-Young Kim; Ho-Young Lee
Journal:  FEBS J       Date:  2009-07-31       Impact factor: 5.542

7.  New treatment options in the management of glioblastoma multiforme: a focus on bevacizumab.

Authors:  Argirios Moustakas; Teri N Kreisl
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

8.  Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action?

Authors:  A S Tarnawski; J Chai; R Pai; S K Chiou
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

9.  Novel mechanisms and signaling pathways of esophageal ulcer healing: the role of prostaglandin EP2 receptors, cAMP, and pCREB.

Authors:  Amrita Ahluwalia; Dolgor Baatar; Michael K Jones; Andrzej S Tarnawski
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-07-24       Impact factor: 4.052

Review 10.  Inhibition of angiogenesis by NSAIDs: molecular mechanisms and clinical implications.

Authors:  Andrzej S Tarnawski; Michael K Jones
Journal:  J Mol Med (Berl)       Date:  2003-09-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.